ARCHIVES

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

November 15, 2013

Samuels Says Industry Should Pay For Valium Carcinogenicity Tests

March 20, 1981

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

NIH Updates Policy On Large Grants

May 10, 1996

CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP.

November 16, 2007